Anagrelide Hydrochloride
Product Images NDC 68151-2959

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Anagrelide Hydrochloride (NDC 68151-2959). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00172524160

FDA Label Image

Structural Formula (Image 03)

FDA Label Image

Figure 1 (Image 04)

Figure 1 (Image 04)
This document presents data on the mean platelet count of patients with thrombocytosis due to myeloproliferative disorders during therapy with Anagrelide. The data includes the number of patients in the assay and the time on treatment in weeks and years, as well as the mean platelet count at baseline and at various time points during treatment.*
FDA Label Image

Label Image (Lbl681512959)

Label Image (Lbl681512959)
This is a prescription medication called Anagrelide HCL made by Cipla. The provided information includes the strength of the capsules, lot number, expiration date, and a product code.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.